What we do Emmessar Biotech & Nutrition Ltd manufactures specialty fine chemicals and healthcare products, focusing on biotechnology, nutraceuticals, cosmeceuticals, and nanotechnology for chronic ailments. |
Founded in 1,992 |
Market share Recognized R&D leader with international collaborations; niche player in specialty chemicals and healthcare product segments. |
Problem solved Addresses obstinate skin, muscle, bone, and chronic physical ailments using innovative biotech-derived nutritional products. |
Top clients or who we serve B2B and B2C markets primarily in healthcare and specialty chemicals, exporting to USA and Europe. |
Key management Mr. Srinivasa Raghavan Mathurakavi Ayyangar (Managing Director); Mr. Jeyavel Balaiah Nadar (CFO); Mrs. Priyanka Omprakash Sharma (Company Secretary). |
Our journey and innovations Since 1992, evolved from specialty chemicals to healthcare biotech; pioneering VedaCeuticals integrating Ayurveda and nanotech; partnered with US-based Vibrant Life. |
Where we operate Domestic markets in India and international exports mainly to the USA and Europe. |
Top products or what we offer Healthcare products targeting skin, muscle, bone ailments; specialty fine chemicals; VedaCeuticals combining biotech and Ayurveda. |
Top brands VedaCeuticals - pioneering blend of biotechnology, nutraceuticals, and Ayurveda with nanotechnology. |
Raw materials needed Specialty chemicals serving as vital micronutrients for biotechnology applications. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue from healthcare products (recurring) and lease income (stable, recurring). |
Our industry position Niche leader in specialty chemicals with expanding presence in innovative healthcare nutraceuticals and cosmeceuticals. |
Financial highlights FY 2024-25 revenue Rs. 261.96 Lakhs; net profit Rs. 31.62 Lakhs; steady growth from Rs. 254.73 Lakhs revenue previous year. |
Geographical revenue split Approximately 59% revenue from India; 41% from international markets. |
Order book - |
Whats driving growth Innovations in biotechnology and healthcare products; international collaborations; expanding nutraceutical & cosmeceutical demand. |
Our future plans Focus on R&D, expanding healthcare product offerings integrating Ayurveda and nanotech; new market penetration. |
Our green promise - |
Our people and values Committed to R&D excellence, ethical governance, employee well-being, and compliance. |
Key challenges ahead Managing industry competition, regulatory changes, and scaling R&D efforts effectively. |
Interesting facts Pioneered VedaCeuticals through a unique blend of biotech and Ayurveda; recognized by DSIR for R&D excellence. |
Risks and strategy Mitigates risks through diversification, robust internal controls, and strategic collaborations for innovation. |
